Share on StockTwits

Stryker (NYSE:SYK) Director Ronda E. Stryker unloaded 7,000 shares of Stryker stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $81.01, for a total value of $567,070.00. Following the completion of the sale, the director now directly owns 175,605 shares of the company’s stock, valued at approximately $14,225,761. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Stryker (NYSE:SYK) traded down 0.60% on Friday, hitting $82.40. The stock had a trading volume of 210,789 shares. Stryker has a one year low of $66.44 and a one year high of $86.93. The stock’s 50-day moving average is $81.57 and its 200-day moving average is $81.4. The company has a market cap of $31.195 billion and a P/E ratio of 46.31.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, July 17th. The company reported $1.08 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.08. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the company posted $1.00 earnings per share. Stryker’s revenue was up 6.8% compared to the same quarter last year. On average, analysts predict that Stryker will post $4.77 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend is Friday, September 26th.

A number of analysts have recently weighed in on SYK shares. Analysts at Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, August 12th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $86.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $90.00 price target on the stock, up previously from $85.00. Eight research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $86.18.

Stryker Corporation (NYSE:SYK) is a medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.